When drug companies put profits before the health and safety of patients, they should be held accountable for their actions.
When drug companies are negligent, they should be held accountable for their actions.
When drug companies realized the potential to expand stimulant sales to adults, they devised a new market, to which Schwarz attributes the rising recreational use of ADHD drugs by students, professors, shift workers, doctors and others with demanding schedules.
Universities are particularly sensitive to university space, resources and / or faculty being involved in outside activities during their working hours, and also for potential conflicts of interest, in which your university research could be biased by receiving outside funding from an inappropriate source, as
when a drug company has a vested interest in the outcome of your independent research.
Not exact matches
But
when they broached the idea of developing such a vaccine with
drug companies, nearly all of them said, «No, thank you very much, but we're not interested,» recalls Schiller in a Lasker Foundation interview.
«
When you put these two things together, you've got a novel new
drug,» says Steve Gilman, the
company's chief scientific officer.
«
When you have a
drug company up against a difficult disease that many others have failed to cure, be more skeptical.
On average, the 30 large and small pharmaceutical and biotech
companies IDEA Pharma examined got just 11 % of their 2017 revenue from
drugs developed within the past five years, says Mike Rea, the firm's CEO and one of the most insightful people I've met — no exaggeration —
when it comes to pinpointing innovation choke points in the
drug industry.
Capping off 2017, the
company say its stock jump 3.9 %
when Metro Inc. began selling back the majority of its Couche - Tard shares — about $ 1.55 billion worth — to help fund its purchase of sister
drug store chain Jean Coutu Group Inc..
And within a span of six weeks this fall, Hillary Clinton caused a drop in biotech stocks with a tweet calling for greater regulation of
drug prices, then single - handedly tanked stocks of private - corrections
companies when she tweeted about prison reform.
On the surface, Papa seems to have gotten an extraordinarily generous deal to turn around the beleaguered
drug company: Not only is his salary more than twice what it was
when he was CEO of Perrigo (prgo), a
company nearly three times as valuable as Valeant (vrx), it's also especially good considering Valeant's stock price has fallen nearly 67 % since he took over.
«
When it comes to making iPhones, it is detrimental to your
company to
drug test employees,» Williams says, half in jest.
KIND bars faced some problematic press in 2015 as well,
when a warning letter from the U.S. Food and
Drug Administration said several of the
company's products weren't as healthy as advertised.
How about buying a global pharmaceutical
company Sterling
Drug when you are Eastman Kodak?
The other thing that concerns me is
when other
drug companies like Pfizer, the ones that you may have in mind, are about to raise prices.
Edwin Matos co-founded
drug - safety consulting
company BioPoint in 2011, but his dreams of becoming a successful business owner began long before that,
when he was the young son of immigrants growing up in the Bronx.
Revenue growth has slowed as many
companies sink more resources into developing the next blockbuster
drug; what's more, the «patent cliff» for the last round of megabillion - dollar
drugs —
when generics firms typically see a sales spurt — happened a few years ago.
Her
company, Sprout Pharmaceuticals, made headlines in August
when a
drug it created became the first FDA approved
drug to boost a woman's sex drive.
The
company has developed an injectable liquid that turns solid
when it enters the body to aid in (among other things)
drug delivery; it's also invented a polymer - based artificial muscle — similar to Rajagopalan's abandoned PhD project — used in compression wear to counter pain.
When Sarepta Therapeutics nabbed a pioneering approval for a Duchenne muscular dystrophy (DMD)
drug last year, it won more than just bragging rights and a controversial FDA approval: the firm also landed a coveted «priority review voucher,» which can either be sold off to another
company or used to slash the review period for a future Sarepta treatment.
In fact, if you believe Ackman's math, Valeant goes from one of the industry's stingiest
companies when it comes to R&D, as critics contend, to one of the biggest spenders on
drug research.
Her seemingly well - orchestrated announcement of diabetes along with a sponsorship deal with a diabetes
drug company came off as insincere to many at the time, especially
when they also perceived that the lifestyle her brand promotes could be a contributing cause.
The
company said a late - stage trial of its cancer
drug Abraxane met its main goal of improving the patient's time of survival without worsening skin cancer,
when compared to standard chemotherapy.
Now Mylan appears to be learning the same hard lesson this week that Martin Shkreli and Valeant (vrx) learned last year: Investors love
when pharmaceutical
companies raise
drug prices — until everybody else gets really upset about it.
Such big winners stopped showing up a few years ago, leaving the large
drug companies watching the calendar for the day
when earnings would be hurt by the loss of key patent protections.
Bayer said in a statement that it doesn't control the cost for patients at the pharmacy, because copays are determined by insurers and pharmacy - benefit managers — an argument that pharmaceuticals
companies have long made
when facing criticism over
drug prices.
The Ranbaxy debacle crossed a crucial threshold in the fall of 2004,
when a senior
company executive disclosed to a subcommittee of the Board of Directors that the
company had committed a massive and ongoing fraud, and that over 200
drug products in more than 40 countries had been submitted to regulators with elements of fabricated data.
On November 21st, a relatively small biotech
company named Gilead Sciences (GILD) made headline news in the pharmaceutical investment community
when it acquired a little - known hepatitis C
drug developer named Pharmasset Inc. (VRUS), for $ 10.8 billion, in an all - cash deal.
Things got even better for Sprout a day after the F.D.A. approval,
when Valeant Pharmaceuticals International, a
drug company whose deal - making acumen had made it a stock - market darling, bought Sprout for an astonishing $ 1 billion — twice its value just two months earlier.
She added that Mylan had responded promptly
when the Food and
Drug Administration criticized the
company's advertisement in 2012, and that the EpiPen had become more expensive because Mylan had invested in public awareness and improving the device.
Drug companies became a favorite villain during the presidential campaign when Democratic candidates Hillary Clinton and Bernie Sanders beat on «Pharma Bro» Martin Shkreli for raising a drug price 5,00
Drug companies became a favorite villain during the presidential campaign
when Democratic candidates Hillary Clinton and Bernie Sanders beat on «Pharma Bro» Martin Shkreli for raising a
drug price 5,00
drug price 5,000 %.
Nevertheless,
when one reads, for instance, of how the Eli Lilly
company used homeless alcoholics for testing experimental
drugs, it is hard not to believe that such guinea pigs are being exploited, even if they may welcome their improved living conditions during the course of the research.
It is true that pharm
companies are making HUGE adjustmens to the pricing of these
drugs when being sold and distributed to people here.
When I think about the millions of Americans who can not afford basic healthcare while insurance and
drug companies announce record profits, I worry.
Dr. King started a pharmaceutical
company in Asheville, N.C., to sell homeopathic
drugs when he could not get them manufactured to his specifications for his health practice in Ohio.
Jeff left the
company in 2003 due to missed work commitments and
drug problems, while Matt continued until 2005
when he was released from the
company.
I am also, as I have mentioned earlier, concerned that this organization (and others of the same genre) are very similar to the «30 - day wonder» mental health /
drug addiction clinics that sprung up across the landscape, back
when health insurance
companies started authorizing up to 30 - days of in - patient care for such conditions.
It could be argued that these types of gifts are wrong — they certainly can influence prescribing practice — but they're hardly trips to the Bahamas or free cars or whatever else people imagine
when they hear «
drug company gifts to doctors».
I think people in the U.S. wait on
drug companies to tell us
when something is okay to take... where were they
when our ancestors were already doing this?
«For the past few months I have been working to pass the Erie County Pharmaceutical Water Pollution Act - a bill that would ensure pharmaceutical
companies pay their fair share
when it comes to the safe disposal of unused prescription
drugs.
«We can't do that
when the
companies continue to pump these out like
drug dealers on the street corners.»
The value of stock in a multiple sclerosis
drug company - which includes large holdings by members of Congress - collapsed Tuesday
when company officials announced the
drug failed during recent clinical trials.
When 2 years ago Hackett discovered a new way of using a lipid to link
drugs to the soluble protein albumin, and that the combination showed promise in improving the bioavailability of the chemotherapy agent paclitaxel, he and his adviser thought they had an invention that laid the foundation for a
company.
It is all too easy for physicians to ignore or miss evidence, particularly
when drug or device
companies use aggressive marketing to counter reports that could harm sales.
Synergen, a biotechnology
company based in Boulder, Colorado, stopped the trial involving 700 patients
when interim analysis of data showed that the
drug, called Antril, was not working.
In this collaboration, Dickerson designed the synthesis of
drugs from precursor compounds prior to scheduling,
when they are not available from research supply
companies.
Foreign pharmaceutical
companies, even those located in low - cost countries, «recognize that
when it comes to
drugs that can be worth a billion dollars a year, a lot more important than labor costs [is] how quickly can you get through FDA,» Finegold says.
When Theravance, the
company in South San Francisco, California, that developed the
drug, designed the large phase III clinical trials needed for approval, the FDA simply required a demonstration that the
drug eliminated symptoms of infection as reliably as the approved antibiotic vancomycin.
The
company was formed in January,
when the
drug giant Abbott split into two entities, one of them being AbbVie.
Germany's emotionally charged abortion debate was thrown into deeper turmoil last week
when MPs discussed whether it was appropriate for them to invite the
drugs company Hoechst to market the «abortion pill» RU486 in Germany.